Medigen Biotechnology Corp. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 174.871 million compared to TWD 140.307 million a year ago. Operating loss was TWD 499.799 million compared to TWD 215.117 million a year ago. Net loss was TWD 129.251 million compared to TWD 90.280 million a year ago. Basic loss per share was TWD 0.93 compared to TWD 0.65 a year ago. For the half year, sales was TWD 360.525 million compared to TWD 271.361 million a year ago. Operating loss was TWD 768.381 million compared to TWD 376.958 million a year ago. Net loss was TWD 193.351 million compared to TWD 160.769 million a year ago. Basic loss per share was TWD 1.39 compared to TWD 1.16 a year ago.